Ledger.Open graph →
SEC Form D · filed August 22, 2014

PrimeGen Biotech LLC

Offering
$17.6M
Sold
$17.6M
Exemption
Rule 506(b)
Industry
Other
Location
Santa Ana, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Andranik S. Aprikyan · Seattle, WAExec · DirectorEric Zimits · San Francisco, CADirectorMichael Hess · Annapolis, MDDirectorJackie Berterretche · San Francisco, CAExec · DirectorChris Mckay · San Francsico, CADirectorNathaniel V. Henshaw · Brunswick, MEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗